Description
Tirzepatide 10mg from Polaris Peptides is a lyophilised research peptide with over 99% purity confirmed by HPLC-MS. Tirzepatide is a dual GIP / GLP-1 receptor agonist (also known as LY3298176, twincretin), supplied vacuum-sealed and sold strictly for laboratory research.
At $89.00 this vial works out to $8.90 per milligram. It sits in the middle of our range, a practical size for full study runs without committing to a bulk vial.
What Is Tirzepatide 10mg?
Tirzepatide is a 39-amino-acid synthetic peptide built on the GIP (glucose-dependent insulinotropic polypeptide) backbone and engineered to activate both GIP and GLP-1 receptors. A C-20 fatty diacid moiety lets it bind albumin, giving it a once-weekly profile in published pharmacology. It was the first dual incretin agonist to move through late-stage clinical work.
Because it hits two incretin pathways at once, tirzepatide is the go-to compound for researchers asking what GIP adds on top of GLP-1. Studies comparing it head-to-head with semaglutide have made it one of the most cited peptides in metabolic research over the past few years.
Tirzepatide 10mg Specifications
| Product | Tirzepatide 10mg |
|---|---|
| Compound | Tirzepatide |
| Also known as | LY3298176, twincretin |
| Class | Dual GIP / GLP-1 receptor agonist |
| CAS number | 2023788-19-2 |
| Amount | 10mg |
| Form | Lyophilised powder |
| Purity | >99% (HPLC-MS) |
| Packaging | Vacuum-sealed |
| Storage | −20 °C dry; 2–8 °C once reconstituted |
| SKU | PLT10 |
Tirzepatide Research Areas
Published studies on Tirzepatide cover several areas. The list below summarises the main ones so you can see where it fits your work.
- Dual incretin pharmacology: how combined GIP and GLP-1 receptor activation differs from single-receptor agonism.
- Adipose tissue biology: GIP receptor effects on fat storage, lipid handling and insulin sensitivity in adipocytes.
- Glycaemic control models: insulin secretion, glucagon suppression and HbA1c-related endpoints in preclinical work.
- Body-weight regulation: energy intake and expenditure in diet-induced obesity models.
- Liver fat research: markers relevant to fatty liver models, an area of active investigation.
Storing and Handling Tirzepatide 10mg
Store unopened vials at −20 °C, where the dry powder stays stable for long periods. Before reconstitution, let the vial reach room temperature to stop condensation forming inside. Add bacteriostatic water or another lab-grade solvent slowly down the side of the vial and swirl gently rather than shaking. Once reconstituted, keep it at 2–8 °C and complete your work within 28 days.
Why Order Tirzepatide From Polaris Peptides
Every batch of Tirzepatide we sell is checked by HPLC-MS for identity and purity before it is listed. Vials are vacuum-sealed to keep moisture out and labelled with the exact amount. If you are comparing suppliers, ask for the batch analysis and check it against the label. That is the standard we hold ourselves to.
How Tirzepatide 10mg Is Tested
We use two methods together. High-performance liquid chromatography (HPLC) separates the contents of a sample so we can see how much of it is the target compound and how much is anything else, such as truncated sequences or leftover synthesis reagents. Mass spectrometry (MS) then weighs the molecules, which confirms that the main peak really is Tirzepatide and not a look-alike. A result above 99% on both counts is what earns a batch a place in our catalogue. Lots that fall short are not sold.
Related Research Peptides
Tirzepatide is also available in other sizes: Tirzepatide 5mg, Tirzepatide 30mg, Tirzepatide 50mg, Tirzepatide 60mg.
Researchers working with Tirzepatide 10mg often look at Semaglutide 10mg, Retatrutide 5mg, Mazdutide 6mg, Survodutide 5mg. Browse the full GLP-1 & GIP Analogues collection, or see every compound in the peptide shop.
Tirzepatide 10mg FAQ
What makes tirzepatide a ‘dual agonist’?
It is designed to activate two receptors, GIP and GLP-1, with a single molecule. Semaglutide only targets GLP-1.
How does tirzepatide compare with retatrutide?
Retatrutide adds glucagon receptor activity on top of GIP and GLP-1, making it a triple agonist. Tirzepatide is the dual-agonist step between semaglutide and retatrutide.
What purity is Tirzepatide 10mg?
Over 99%, confirmed by HPLC-MS on every batch.
How should Tirzepatide be stored?
Dry powder at −20 °C. After reconstitution, 2–8 °C, used within 28 days.
Is Tirzepatide 10mg for human use?
No. It is sold for laboratory and in-vitro research only. It is not a drug, food or cosmetic and is not for human or veterinary use.
References
Read the published research on Tirzepatide at PubMed (U.S. National Library of Medicine).
For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the FDA.
Reviews
There are no reviews yet.